Newsroom

Publications

Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study

13 Jun 2018

Diverse antimalarials from whole-cell phenotypic screens disrupt malaria parasite ion and volume homeostasis

11 Jun 2018

Rapport de gestion 2017

06 Jun 2018
All publications

Events

28
Jun

Clinical Research in Resource Limited Settings - Mission Impossible or Role Model for Future Drug Development?

28 June 2018
Basel, Switzerland
28
Jun

Swiss TPH Summer Symposium

28 June 2018
Basel, Switzerland
All events